Showing results (221-230 of 236) with videos related to
Sort By:
Pageof 24
JACC. Basic to Translational Science|July 12, 2022
Specialized Proresolving Mediators Protect Against Experimental Autoimmune Myocarditis by Modulating Ca2+ Handling and NRF2 ActivationAlmudena Val-Blasco, Patricia Prieto, Rafael Iñigo Jaén, et al.International Journal of Molecular Sciences|January 21, 2023
Analysis of Differentially Expressed MicroRNAs in Serum and Lung Tissues from Individuals with Severe Asthma Treated with Oral GlucocorticoidsMarta Gil-Martínez, Clara Lorente-Sorolla, José M Rodrigo-Muñoz, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 8, 2026
Addressing unmet needs in long-term survivors of ovarian cancer (ENGOT ov40/NOGGO S13/GEICO 71-R/Expression VI): insights from a Spanish cohortMaria-Pilar Barretina-Ginesta, Ainhoa Madariaga, Marta Gil-Martín, et al.BMC Cancer|July 22, 2024
ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancerAlexandra Leary, Purificación Estévez-García, Renaud Sabatier, et al.BMC Medical Genetics|September 10, 2011
Genetic diagnosis of X-linked dominant Hypophosphatemic Rickets in a cohort study: tubular reabsorption of phosphate and 1,25(OH)2D serum levels are associated with PHEX mutation typeMarcos Morey, Lidia Castro-Feijóo, Jesús Barreiro, et al.Nature Medicine|January 17, 2025
Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trialAlicia F C Okines, Giuseppe Curigliano, Nobumasa Mizuno, et al.European Journal of Cancer (Oxford, England : 1990)|April 10, 2026
Implementing a molecular prescreening strategy for tumors without public NGS access in a cancer center network: Results from the PREICO projectPaula Sàbat, Maria Ajenjo-Bauza, Cinta Hierro, et al.International Journal of Surgery (London, England)|November 14, 2021
P-POSSUM as mortality predictor in COVID-19-infected patients submitted to emergency digestive surgery. A retrospective cohort studyZoilo Madrazo, Javier Osorio, Sebastián Videla, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2023
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E TrialShannon N Westin, Kathleen Moore, Hye Sook Chon, et al.International Journal of Surgery (London, England)|September 11, 2022
Use of failure-to-rescue after emergency surgery as a dynamic indicator of hospital resilience during the COVID-19 pandemic. A multicenter retrospective propensity score-matched cohort studyJavier Osorio, Zoilo Madrazo, Sebastian Videla, et al.Pageof 24